Detalhe da pesquisa
1.
Venous and Arterial Thrombosis in Patients with VEXAS Syndrome.
Blood
; 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306657
2.
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q).
Br J Haematol
; 204(4): 1243-1248, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38083865
3.
VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management.
Am J Hematol
; 99(2): 284-299, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950858
4.
Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases.
Am J Hematol
; 99(1): 21-27, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772442
5.
Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
Am J Hematol
; 99(1): E1-E4, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37688525
6.
Targeted testing of bone marrow specimens with cytoplasmic vacuolization to identify previously undiagnosed cases of VEXAS syndrome.
Rheumatology (Oxford)
; 62(12): 3947-3951, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37228016
7.
Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual-color dual-fusion FISH studies.
Genes Chromosomes Cancer
; 61(10): 629-634, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639830
8.
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases.
Br J Haematol
; 196(4): 975-983, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34729775
9.
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases.
Am J Hematol
; 97(5): 630-637, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35156231
10.
Identification of a novel KMT2A/GIMAP8 gene fusion in a pediatric patient with acute undifferentiated leukemia.
Genes Chromosomes Cancer
; 60(2): 108-111, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078871
11.
Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1.
Mod Pathol
; 34(1): 20-31, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694616
12.
Now You See Me: Acute and Recurrent Severe Abdominal Pain Associated With Bowel Edema.
Gastroenterology
; 166(3): e10-e12, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926127
13.
Correction to: Hybridization capture-based next-generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis.
Mod Pathol
; 33(3): 514, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591496
14.
Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis.
Mod Pathol
; 33(3): 334-343, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471587
15.
Systematic use of fluorescence in-situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid/lymphoid neoplasms.
Histopathology
; 76(7): 1042-1054, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32083752
16.
Mast cell cytomorphology and treatment outcome in mast cell leukemia.
Am J Hematol
; 99(1): E5-E8, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37732882
17.
IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.
Am J Hematol
; 94(3): 338-345, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575108
18.
De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.
Mod Pathol
; 31(5): 705-717, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29327715
19.
Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival.
Haematologica
; 108(9): 2542-2545, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794509
20.
Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases.
Am J Hematol
; 93(12): 1461-1466, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30152525